GeneDx Holdings Management
Management criteria checks 3/4
GeneDx Holdings' CEO is Katherine Stueland, appointed in May 2022, has a tenure of 2.5 years. total yearly compensation is $3.58M, comprised of 18.9% salary and 81.1% bonuses, including company stock and options. directly owns 0.38% of the company’s shares, worth $7.49M. The average tenure of the management team and the board of directors is 1.1 years and 3.3 years respectively.
Key information
Katherine Stueland
Chief executive officer
US$3.6m
Total compensation
| CEO salary percentage | 18.9% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.4% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
US$76.67 - That's What Analysts Think GeneDx Holdings Corp. (NASDAQ:WGS) Is Worth After These Results
Nov 01
GeneDx Holdings: Phenomenal Gains, More Upside Potential In Medium Term
Oct 30GeneDx Holdings: Stock To Keep Outperforming As Business Momentum Persists
Oct 21After Leaping 53% GeneDx Holdings Corp. (NASDAQ:WGS) Shares Are Not Flying Under The Radar
Oct 04Is GeneDx Holdings (NASDAQ:WGS) Using Debt Sensibly?
Aug 29GeneDx Holdings: Profits On The Horizon For AI Driven Health Platform
Aug 19Market Participants Recognise GeneDx Holdings Corp.'s (NASDAQ:WGS) Revenues Pushing Shares 28% Higher
Jul 27GeneDx Holdings Corp.'s (NASDAQ:WGS) 30% Jump Shows Its Popularity With Investors
Jun 12GeneDx Holdings: Mapping A Path To Leadership In Pediatric Genetic Testing
Jun 06Further Upside For GeneDx Holdings Corp. (NASDAQ:WGS) Shares Could Introduce Price Risks After 42% Bounce
Apr 24GeneDx Holdings Corp. (NASDAQ:WGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$9.13
Feb 23The Market Lifts GeneDx Holdings Corp. (NASDAQ:WGS) Shares 107% But It Can Do More
Feb 22Improved Revenues Required Before GeneDx Holdings Corp. (NASDAQ:WGS) Stock's 56% Jump Looks Justified
Dec 20Analyst Forecasts Just Became More Bearish On GeneDx Holdings Corp. (NASDAQ:WGS)
Nov 02Not Many Are Piling Into GeneDx Holdings Corp. (NASDAQ:WGS) Stock Yet As It Plummets 49%
Nov 01Sema4 names Kevin Feeley as CFO
Aug 26Things Look Grim For Sema4 Holdings Corp. (NASDAQ:SMFR) After Today's Downgrade
Aug 20Sema4 Holdings Corp. (NASDAQ:SMFR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 19Sema4 Q2 2022 Earnings Preview
Aug 12Sema4 Holdings, Big Data For Precision Medicine Solutions
Jul 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$83m |
| Jun 30 2024 | n/a | n/a | -US$117m |
| Mar 31 2024 | n/a | n/a | -US$135m |
| Dec 31 2023 | US$4m | US$675k | -US$176m |
| Sep 30 2023 | n/a | n/a | -US$459m |
| Jun 30 2023 | n/a | n/a | -US$494m |
| Mar 31 2023 | n/a | n/a | -US$533m |
| Dec 31 2022 | US$12m | US$454k | -US$549m |
Compensation vs Market: Katherine's total compensation ($USD3.58M) is below average for companies of similar size in the US market ($USD5.35M).
Compensation vs Earnings: Katherine's compensation has been consistent with company performance over the past year.
CEO
Katherine Stueland (48 yo)
2.5yrs
Tenure
US$3,575,335
Compensation
Ms. Katherine A. Stueland serves as Chief Executive Officer & Director at GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp.) since May 2022 and serves as its President. She served as President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$3.58m | 0.38% $ 7.5m | |
| Chief Financial Officer | 2.3yrs | US$1.57m | 0.16% $ 3.2m | |
| Head of Operations | 1.1yrs | no data | no data | |
| Chief Product & Technology Officer | less than a year | no data | no data | |
| Head of People Strategy | less than a year | no data | no data | |
| Chief Medical Officer | 2.5yrs | no data | no data | |
| Chief Growth Officer | 1.2yrs | no data | no data | |
| Chief of Staff | no data | no data | no data | |
| Head of Medical Affairs | less than a year | no data | no data |
1.1yrs
Average Tenure
Experienced Management: WGS's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$3.58m | 0.38% $ 7.5m | |
| Independent Director | 7yrs | US$207.98k | 0.71% $ 13.8m | |
| Director | 2.6yrs | US$192.98k | 0.10% $ 2.0m | |
| Independent Director | 2.8yrs | US$207.98k | 0.026% $ 511.9k | |
| Independent Director | 4.3yrs | US$200.48k | 0.028% $ 539.4k | |
| Chairman of the Board | 3.3yrs | US$992.46k | 0.69% $ 13.4m | |
| Independent Director | 4.2yrs | US$206.73k | 0.030% $ 593.3k |
3.3yrs
Average Tenure
50.5yo
Average Age
Experienced Board: WGS's board of directors are considered experienced (3.3 years average tenure).